Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Adjei

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|July 19, 2001
Blocking oncogenic Ras signaling for cancer therapyA A Adjei
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumorsA A Adjei
Current Pharmaceutical Design|September 20, 2001
Ras signaling pathway proteins as therapeutic targetsA A Adjei
Current Opinion in Pulmonary Medicine|July 27, 2000
Management of small cell cancer of the lungA A Adjei
British Journal of Clinical Pharmacology|October 6, 1999
A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancerA A Adjei
Investigational New Drugs|November 11, 1999
Current status of pyrazoloacridine as an anticancer agentA A Adjei
Oncology (Williston Park, N.Y.)|March 17, 2001
Gemcitabine and Pemetrexed disodium in treating breast cancerA A Adjei
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Gemcitabine and pemetrexed disodium combinations in vitro and in vivoA A Adjei
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Clinical studies of pemetrexed and gemcitabine combinationsA A Adjei
Current Pharmaceutical Design|May 2, 2000
Signal transduction pathway targets for anticancer drug discoveryA A Adjei
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|July 19, 2001
Blocking oncogenic Ras signaling for cancer therapyA A Adjei
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumorsA A Adjei
Current Pharmaceutical Design|September 20, 2001
Ras signaling pathway proteins as therapeutic targetsA A Adjei
Current Opinion in Pulmonary Medicine|July 27, 2000
Management of small cell cancer of the lungA A Adjei
British Journal of Clinical Pharmacology|October 6, 1999
A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancerA A Adjei
Investigational New Drugs|November 11, 1999
Current status of pyrazoloacridine as an anticancer agentA A Adjei
Oncology (Williston Park, N.Y.)|March 17, 2001
Gemcitabine and Pemetrexed disodium in treating breast cancerA A Adjei
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Gemcitabine and pemetrexed disodium combinations in vitro and in vivoA A Adjei
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Clinical studies of pemetrexed and gemcitabine combinationsA A Adjei
Current Pharmaceutical Design|May 2, 2000
Signal transduction pathway targets for anticancer drug discoveryA A Adjei
Pageof 9